drugset
drugset / Trial / NCT01396681

Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer

NCT01396681 ↗

Phase 2 Completed 70 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

This is a phase Ⅱ Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiation With Gemcitabine in Patients With Resected Pancreatic Cancer.

Timeline

Start
2004-12
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 60 mg/m2 —
Subject Gemcitabine Small molecule 1200 mg/m2 —

Indications

malignant pancreatic neoplasm